{
    "id": "5e3c6850b5b409ea5300001f",
    "question": "Is bortezomib a Proteasome inhibitor?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine if bortezomib is a proteasome inhibitor, we need to understand what it is and how it works. Bortezomib is a medication used primarily in the treatment of certain types of blood cancers, such as multiple myeloma and mantle cell lymphoma. It is known to target and disrupt the function of a specific protein complex in the cell called the proteasome. The proteasome is a part of the cell's waste management system, responsible for breaking down and recycling damaged or unwanted proteins. By inhibiting the proteasome, bortezomib prevents the breakdown of certain proteins that are essential for the growth and survival of cancer cells, ultimately leading to their death. This mechanism of action is characteristic of proteasome inhibitors. Therefore, based on its mechanism of action, bortezomib can be classified as a proteasome inhibitor.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 28.379196882247925
}